Literature DB >> 24900227

Exploring α7-Nicotinic Receptor Ligand Diversity by Scaffold Enumeration from the Chemical Universe Database GDB.

Noemi Garcia-Delgado1, Sonia Bertrand2, Kong T Nguyen1, Ruud van Deursen1, Daniel Bertrand2, Jean-Louis Reymond1.   

Abstract

Virtual analogues (1167860 compounds) of the nicotinic α7-receptor (α7 nAChR) ligands PNU-282,987 and SSR180711 were generated from the chemical universe database GDB-11 by extracting all aliphatic diamine analogues of the aminoquinuclidine and 1,4-diazabicyclo[3.2.2]nonane scaffolds of these ligands and converting them to the corresponding aryl amides using five different aromatic acyl groups. The library was ranked by docking to the nicotinic binding site of the acetylcholine binding protein (AChBP, 1UW6.pdb) using Autodock and Glide. Thirty-eight ligands derived from the best docking hits were synthesized and tested for modulation of the acetylcholine signal at the human α7 nAChR receptor expressed in Xenopus oocytes, leading to competitive and noncompetitive antagonists with IC50 = 5-7 μM. These experiments demonstrate the first example of using GDB in a fragment-based approach by diversifying the scaffold of known drugs.

Entities:  

Keywords:  Virtual libraries; docking; electrophysiology; nicotinic receptor; virtual screening

Year:  2010        PMID: 24900227      PMCID: PMC4007948          DOI: 10.1021/ml100125f

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  25 in total

1.  Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy.

Authors:  Richard A Friesner; Jay L Banks; Robert B Murphy; Thomas A Halgren; Jasna J Klicic; Daniel T Mainz; Matthew P Repasky; Eric H Knoll; Mee Shelley; Jason K Perry; David E Shaw; Perry Francis; Peter S Shenkin
Journal:  J Med Chem       Date:  2004-03-25       Impact factor: 7.446

2.  Virtual exploration of the small-molecule chemical universe below 160 Daltons.

Authors:  Tobias Fink; Heinz Bruggesser; Jean-Louis Reymond
Journal:  Angew Chem Int Ed Engl       Date:  2005-02-25       Impact factor: 15.336

Review 3.  Central nicotinic receptors: structure, function, ligands, and therapeutic potential.

Authors:  M Novella Romanelli; Paola Gratteri; Luca Guandalini; Elisabetta Martini; Claudia Bonaccini; Fulvio Gualtieri
Journal:  ChemMedChem       Date:  2007-06       Impact factor: 3.466

4.  An automated system for intracellular and intranuclear injection.

Authors:  Ron C Hogg; Florence Bandelier; Audrey Benoit; Roland Dosch; Daniel Bertrand
Journal:  J Neurosci Methods       Date:  2007-12-08       Impact factor: 2.390

5.  970 million druglike small molecules for virtual screening in the chemical universe database GDB-13.

Authors:  Lorenz C Blum; Jean-Louis Reymond
Journal:  J Am Chem Soc       Date:  2009-07-01       Impact factor: 15.419

6.  3-(aminomethyl)piperazine-2,5-dione as a novel NMDA glycine site inhibitor from the chemical universe database GDB.

Authors:  Kong Thong Nguyen; Erika Luethi; Salahuddin Syed; Stephan Urwyler; Sonia Bertrand; Daniel Bertrand; Jean-Louis Reymond
Journal:  Bioorg Med Chem Lett       Date:  2009-04-10       Impact factor: 2.823

7.  Discovery and structure-activity relationship of quinuclidine benzamides as agonists of alpha7 nicotinic acetylcholine receptors.

Authors:  Alice L Bodnar; Luz A Cortes-Burgos; Karen K Cook; Dac M Dinh; Vincent E Groppi; Mihaly Hajos; Nicole R Higdon; William E Hoffmann; Raymond S Hurst; Jason K Myers; Bruce N Rogers; Theron M Wall; Mark L Wolfe; Erik Wong
Journal:  J Med Chem       Date:  2005-02-24       Impact factor: 7.446

8.  The selective nicotinic acetylcholine receptor alpha7 agonist JN403 is active in animal models of cognition, sensory gating, epilepsy and pain.

Authors:  Dominik Feuerbach; Kurt Lingenhoehl; Hans-Rudolf Olpe; Annick Vassout; Conrad Gentsch; Frederique Chaperon; Joachim Nozulak; Albert Enz; Graeme Bilbe; Kevin McAllister; Daniel Hoyer
Journal:  Neuropharmacology       Date:  2008-08-28       Impact factor: 5.250

9.  Synthesis of 1-azabicyclo[3.3.0]octane derivatives and their effects as piracetam-like nootropics.

Authors:  M Oka; Y Matsumoto; K Hirooka; T Suzuki
Journal:  Chem Pharm Bull (Tokyo)       Date:  2000-08       Impact factor: 1.645

10.  Use of acetylcholine binding protein in the search for novel alpha7 nicotinic receptor ligands. In silico docking, pharmacological screening, and X-ray analysis.

Authors:  Chris Ulens; Atilla Akdemir; Aldo Jongejan; Rene van Elk; Sonia Bertrand; Anastassis Perrakis; Rob Leurs; August B Smit; Titia K Sixma; Daniel Bertrand; Iwan J P de Esch
Journal:  J Med Chem       Date:  2009-04-23       Impact factor: 7.446

View more
  4 in total

Review 1.  Exploring chemical space for drug discovery using the chemical universe database.

Authors:  Jean-Louis Reymond; Mahendra Awale
Journal:  ACS Chem Neurosci       Date:  2012-04-25       Impact factor: 4.418

2.  Visualisation and subsets of the chemical universe database GDB-13 for virtual screening.

Authors:  Lorenz C Blum; Ruud van Deursen; Jean-Louis Reymond
Journal:  J Comput Aided Mol Des       Date:  2011-05-27       Impact factor: 3.686

Review 3.  Discovery of potent positive allosteric modulators of the α3β2 nicotinic acetylcholine receptor by a chemical space walk in ChEMBL.

Authors:  Justus J Bürgi; Mahendra Awale; Silvan D Boss; Tifany Schaer; Fabrice Marger; Juan M Viveros-Paredes; Sonia Bertrand; Jürg Gertsch; Daniel Bertrand; Jean-Louis Reymond
Journal:  ACS Chem Neurosci       Date:  2014-03-04       Impact factor: 4.418

4.  Computational exploration of a protein receptor binding space with student proposed peptide ligands.

Authors:  Matthew D King; Paul Phillips; Matthew W Turner; Michael Katz; Sarah Lew; Sarah Bradburn; Tim Andersen; Owen M McDougal
Journal:  Biochem Mol Biol Educ       Date:  2015-11-05       Impact factor: 1.160

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.